Apa, Rosanna
 Distribuzione geografica
Continente #
EU - Europa 3.047
NA - Nord America 2.505
AS - Asia 736
SA - Sud America 17
AF - Africa 8
OC - Oceania 8
Totale 6.321
Nazione #
US - Stati Uniti d'America 2.483
DE - Germania 1.242
SE - Svezia 405
IT - Italia 333
PL - Polonia 269
CN - Cina 268
UA - Ucraina 235
SG - Singapore 227
GB - Regno Unito 146
IE - Irlanda 121
FR - Francia 96
ID - Indonesia 79
FI - Finlandia 75
IN - India 70
BE - Belgio 32
RU - Federazione Russa 31
TR - Turchia 21
CA - Canada 16
IR - Iran 16
NL - Olanda 16
VN - Vietnam 11
ES - Italia 8
HK - Hong Kong 7
JP - Giappone 7
MY - Malesia 7
AU - Australia 6
BR - Brasile 6
NP - Nepal 6
CL - Cile 5
CZ - Repubblica Ceca 5
MX - Messico 5
PH - Filippine 5
RO - Romania 5
AR - Argentina 4
DK - Danimarca 3
HU - Ungheria 3
IQ - Iraq 3
LY - Libia 3
NO - Norvegia 3
PK - Pakistan 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BD - Bangladesh 2
BG - Bulgaria 2
CH - Svizzera 2
CO - Colombia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
AL - Albania 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CM - Camerun 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
KZ - Kazakistan 1
LV - Lettonia 1
MC - Monaco 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.321
Città #
Chandler 588
Warsaw 254
Ashburn 212
Singapore 175
Jacksonville 151
San Mateo 130
Dublin 118
Nürnberg 102
Wilmington 80
New York 75
Fairfield 70
Jakarta 70
Milan 64
Houston 60
Nanjing 59
Woodbridge 59
Ann Arbor 56
Lancaster 53
Boston 48
Dearborn 48
Seattle 44
Marseille 43
Princeton 41
Bremen 40
Rome 40
Munich 37
Cambridge 35
Brussels 29
Helsinki 28
Lawrence 25
University Park 25
Los Angeles 24
Hebei 22
Beijing 19
Izmir 19
Nanchang 18
Redwood City 18
Cattolica 17
Mountain View 17
Zhengzhou 17
Leawood 15
Moscow 15
Redmond 15
Augusta 13
Kraków 12
Shenyang 12
Fremont 11
Hanoi 11
London 11
Shanghai 11
Tianjin 11
Kunming 9
Bari 8
Changsha 8
Jinan 8
Boardman 7
Jiaxing 7
Norwalk 7
Toronto 7
Bologna 6
Frankfurt am Main 6
Hangzhou 6
Kuala Lumpur 6
Ottawa 6
Simi Valley 6
Washington 6
Amsterdam 5
Andover 5
Ardabil 5
Hefei 5
Sacramento 5
Falls Church 4
Gonnosfanadiga 4
Hong Kong 4
Kathmandu 4
Kish 4
Lucknow 4
Monmouth Junction 4
Paris 4
Pune 4
Vienna 4
Angeles City 3
Barcelona 3
Bregano 3
Brescia 3
Budapest 3
Chennai 3
Chicago 3
Guangzhou 3
Gustavo Adolfo Madero 3
Iesi 3
Johannesburg 3
Kashan 3
Kowloon 3
La Ligua 3
Lahore 3
Livorno 3
Melbourne 3
Modena 3
Pescara 3
Totale 3.392
Nome #
Effect of human chorionic gonadotropin administration on pituitary and luteal response to gonadotropin-releasing hormone 353
Insulin-like growth factor (IGF)-I and IGF-II stimulate progesterone production by human luteal cells: role of IGF-I as mediator of growth hormone action 257
Endometriosis and human infertility: a new investigation into the role of eutopic endometrium 221
A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor. 211
CD4+CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome 187
Advisory Board Italiano sulla sindrome dell'ovaio policistico (PCOS): dalle osservazioni all'esperienze cliniche sull'uso del mioinositolo (MYO) e dell'acido alfa-lipoico (ALA) per migliorare i quadri della sindrome] [Article in Italian] 180
Management of vertigo in pregnancy 177
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. 165
Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells. 159
Assessment of insulin resistance in lean women with polycystic ovary syndrome. 148
Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT 148
CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes 135
Prokineticin 1 mRNA expression in the endometrium of healthy women and in the eutopic endometrium of women with endometriosis. 124
Psoriasis and polycystic ovary syndrome: a new link in different phenotypes 110
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase 109
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 109
A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples 105
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 103
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 99
Italian Advisory Board on Polycystic Ovary Syndrome (PCOS): From observations to clinical experiences on the use of myoinositol (MYO) and alpha-lipoic acid (ALA) to improve the clinical features of the syndrome 96
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 95
The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population 93
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 93
Nicotine and cotinine affect the release of vasoactive factors by trophoblast cells and human umbilical vein endothelial cells. 92
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. 90
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 89
Could antispasmodic drug reduce pain during hysterosalpingo-contrast sonography (HyCoSy) in infertile patients? A randomized double-blind clinical trial 88
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial 86
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 84
The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population 83
Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis 81
In vitro effect of unacylated ghrelin and obestatin on human luteal cell function 79
Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells 78
Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action 77
Estrogens and androgens affect human luteal cell function 76
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 76
In vitro effect of unacylated ghrelin and obestatin on human luteal cell function 75
Assessment of insulin resistance in lean women with polycystic ovary syndrome 75
The Performance of Serum Antimullerian Hormone and Antral Follicle Count in Predicting the Ovarian Response in Intrauterine Insemination 75
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 75
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study 73
Circulating irisin levels in functional hypothalamic amenorrhea: a new bone damage index? A pilot study. 71
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function 69
Relationships Between Thyroid Hormones, Insulin-Like Growth Factor-1 and Antioxidant Levels in Hypothalamic Amenorrhea and Impact on Bone Metabolism 68
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial 66
Increased fibulin-1 plasma levels in polycystic ovary syndrome (PCOS) patients: possible contribution to the link between PCOS and cardiovascular risk 65
Plasmatic and Intracellular Markers of Oxidative Stress in Normal Weight and Obese Patients with Polycystic Ovary Syndrome. 64
Hysterosalpingo-contrast-sonography (HyCoSy) in the assessment of tubal patency in endometriosis patients 63
In vitro effect of unacylated ghrelin and obestatin on human luteal cell function 61
Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: A RCT 58
"Hormone of darkness" and human reproductive process: direct regulatory role of melatonin in human corpus luteum 58
Alpha-Lipoic Acid May Improve the Clinical, Endocrine and Metabolic Features of Polycystic Ovary Syndrome through an Insulin-Sensitizing Effect and an Antioxidant Action 57
Psoriasis and polycystic ovary syndrome: A new link in different phenotypes 55
Estrogens and androgens affect human luteal cell function 54
Thyroid Stimulating Hormone (TSH) and Human Corpus Luteum: A Possible Contribution to Reproductive Process 54
Expression, localization and control of activin A release from human umbilical vein endothelial cells. 53
Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination 53
Prokineticin 1, homeobox A10, and progesterone receptor messenger ribonucleic acid expression in primary cultures of endometrial stromal cells isolated from endometrium of healthy women and from eutopic endometrium of women with endometriosis. 52
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study 52
In vitro effect of unacylated ghrelin and obestatin on human luteal cell function 50
Increased fibulin-1 plasma levels in polycystic ovary syndrome (PCOS) patients: possible contribution to the link between PCOS and cardiovascular risk 50
Insulin sensitizers in patients with polycystic ovary syndrome 48
In vitro effect of unacylated ghrelin and obestatin on human luteal cell function 44
A possible role of polycystic ovary syndrome for pregnancy complications in women with psoriasis 43
Urocortin 1 expression and secretion by human umbilical vein endothelial cells: In vitro effects of interleukin 8, interferon γ, lipopolysaccharide, endothelin 1, prostaglandin F-2α, estradiol, progesterone and dexamethasone. 40
Melatonin Treatment May Be Able to Restore Menstrual Cyclicity in Women With PCOS: A Pilot Study 37
Insulin-sensitizing effect and antioxidant action of alpha lipoic acid in oligomenorrheic women with polycystic ovary syndrome 29
Functional hypothalamic amenorrhea: gut microbiota composition and the effects of exogenous estrogen administration 14
Chorioretinal biomarkers in hypothalamic amenorrhea 11
Role of thyroid stimulating hormone in the maintenance and functioning of the human corpus luteum 9
Totale 6.377
Categoria #
all - tutte 23.552
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020624 0 0 0 0 71 140 113 26 69 34 108 63
2020/2021528 21 60 14 60 62 32 61 11 63 15 100 29
2021/2022609 34 49 15 34 25 23 13 113 29 32 97 145
2022/20231.585 177 230 138 251 86 194 66 122 211 18 68 24
2023/2024783 42 185 22 40 55 134 82 42 16 42 57 66
2024/2025376 35 46 123 42 130 0 0 0 0 0 0 0
Totale 6.377